22(top 2%)
papers
709(top 2%)
citations
13(top 2%)
h-index
19(top 2%)
g-index
23
all documents
786
doc citations
326
citing journals

Top Articles

#TitleJournalYearCitations
1Lenalidomide in combination with intravenous rituximab (REVRI) in relapsed/refractory primary CNS lymphoma or primary intraocular lymphoma: a multicenter prospective ‘proof of concept’ phase II study of the French Oculo-Cerebral lymphoma (LOC) Network and the Lymphoma Study Association (LYSA)Annals of Oncology2019147
2Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working PartyBlood2011140
3Analysis of the Ten-Eleven Translocation 2 (TET2) gene in familial myeloproliferative neoplasmsBlood200996
4Waldenström’s macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology201863
5Waldenström's macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology201362
6Germline JAK2 Mutations In The Kinase Domain Are Responsible For Hereditary Thrombocytosis and Are Resistant To JAK2 and HSP90 InhibitorsBlood201346
7Long term follow up of 93 families with myeloproliferative neoplasms: life expectancy and implications of JAK2V617F in the occurrence of complicationsBlood Cells, Molecules, and Diseases201243
8Conditioning intensity in secondary AML with prior myelodysplastic syndrome/myeloproliferative disorders: an EBMT ALWP studyBlood Advances201834
9Deferasirox and Vitamin D Improves Overall Survival in Elderly Patients with Acute Myeloid Leukemia after Demethylating Agents FailurePLoS ONE201333
10Autologous stem cell transplantation for adult acute leukemiaCurrent Opinion in Oncology200230
11Interest of the association azacitidine–lenalidomide as frontline therapy in high-risk myelodysplasia or acute myeloid leukemia with complex karyotypeLeukemia201217
12Single-Unit versus Double-Unit Umbilical Cord Blood Transplantation in Children and Young Adults with Residual Leukemic DiseaseBiology of Blood and Marrow Transplantation201917
13The microenvironment in lymphomas – Dissecting the complex crosstalk between tumor cells and ‘by-stander’ cellsSeminars in Cancer Biology201416
14Invasive Aspergillosis of the Mediastinum and Left Hilum: CT FeaturesAmerican Journal of Roentgenology200413
15Dexamethasone, cisplatin, doxorubicin, cyclophosphamide and etoposide (DPACE) is an effective salvage regimen for multiple myeloma refractory to novel agentsLeukemia and Lymphoma20139
16The Case ∣ The case presentationKidney International20078
17Rituximab as first‐line therapy for acquired haemophilia A: a single‐centre 10‐year experienceHaemophilia20166
18Is Azacitidine (AZA) Really Effective in High Risk MDS Patients with Chromosome 7 Abnormalities (Abn 7)? Results of a Retrospective Study From the GFM and GESMD RegistriesBlood20124
19Management of relapsed or refractory follicular lymphoma patients in daily practice – a French non-interventional studyLeukemia and Lymphoma20182
20Study of V617F JAK2-Positive and JAK2-Negative Patients within 18 Families with Myeloproliferative Disorders (MPD): Disease Characteristics and Evolution, EPOR and MPL Analysis.Blood20060
21Long-Term Follow-up of 94 Families with Myeloproliferative Neoplasms: Implications of the V617F JAK2 mutation, Life Expectancy and Complication RatesBlood20100
22Hematopoietic Multipotent Progenitor Cells Mobilized by G-CSF Can Inhibit GvhdBlood20110
23Interest of the Association Azacitidine-Lenalidomide As Front Line Therapy in High-Risk Myelodysplasia (MDS) or Acute Myeloid Leukemia (AML) with Complex KaryotypeBlood20110